Dihydroxyphenylalanine
This graph shows the total number of publications written about "Dihydroxyphenylalanine" by people in the URMC Research Network by year, and whether "Dihydroxyphenylalanine" was a major or minor topic of these publication.
Below are the most recent publications written about "Dihydroxyphenylalanine" by people in Profiles.
-
Mink JW. Abnormal circuit function in dystonia. Neurology. 2006 Apr 11; 66(7):959.
-
Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R. The role of radiotracer imaging in Parkinson disease. Neurology. 2005 Jan 25; 64(2):208-15.
-
Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Adv Neurol. 2004; 94:163-70.
-
Brooks DJ, Frey KA, Marek KL, Oakes D, Paty D, Prentice R, Shults CW, Stoessl AJ. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Exp Neurol. 2003 Nov; 184 Suppl 1:S68-79.
-
Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology. 2001 Jan 9; 56(1):8-13.
-
Teicher MH, Gallitano AL, Gelbard HA, Evans HK, Marsh ER, Booth RG, Baldessarini RJ. Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum. Brain Res Dev Brain Res. 1991 Nov 19; 63(1-2):229-35.
-
Rivera-Calimlim L. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats. Br J Pharmacol. 1974 Feb; 50(2):259-63.
-
Woolf PD, Jacobs LS, Donofrio R, Burday SZ, Schalch DS. Secondary hypopituitarism: evidence for continuing regulation of hormone release. J Clin Endocrinol Metab. 1974 Jan; 38(1):71-6.
-
Rivera-Calimlim L, Bosmann HB, Penney DP, Lasagna L. Morphologic and biochemical changes in the gut after chronic treatment with L-dopa. J Pharmacol Exp Ther. 1973 Feb; 184(2):440-8.
-
Rivera-Calimlim L. Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa. Br J Pharmacol. 1972 Dec; 46(4):708-13.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
